Amphastar Pharmaceuticals (AMPH) Shares Outstanding (Diluted Average) (2016)

Amphastar Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 4 years, most recently at $46.0 million for Q2 2016.

  • Quarterly results put Shares Outstanding (Diluted Average) at $46.0 million for Q2 2016, up 2.5% from a year ago — trailing twelve months through Jun 2016 was $46.0 million (up 2.5% YoY), and the annual figure for FY2015 was $46709.0, changed.
  • Shares Outstanding (Diluted Average) for Q2 2016 was $46.0 million at Amphastar Pharmaceuticals, down from $46.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for AMPH hit a ceiling of $46.8 million in Q1 2016 and a floor of $38769.0 in Q1 2014.
  • Median Shares Outstanding (Diluted Average) over the past 4 years was $38.8 million (2013), compared with a mean of $24.9 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): plummeted 99.9% in 2014 and later surged 114942.95% in 2015.
  • Amphastar Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $38.9 million in 2013, then crashed by 99.89% to $44644.0 in 2014, then rose by 4.63% to $46709.0 in 2015, then soared by 98313.58% to $46.0 million in 2016.
  • The last three reported values for Shares Outstanding (Diluted Average) were $46.0 million (Q2 2016), $46.8 million (Q1 2016), and $46709.0 (Q4 2015) per Business Quant data.